AkzoNobel Sells Indian Coatings Business to JSW Group in €1.4 Billion Deal
On June 27, 2025, AkzoNobel announced an agreement to sell its stake in AkzoNobel India Ltd. (ANIL) to India’s JSW Group, one of the country’s leading diversified conglomerates. The transaction is valued at approximately €1.4 billion, representing a 22x enterprise value-to-EBITDA multiple, and includes AkzoNobel’s liquid coatings operations in India. However, the powder coatings business and India Research Center will remain fully owned by AkzoNobel.
This divestment marks the first step in AkzoNobel’s strategic portfolio review, announced in October 2024, to focus its resources on leading global coatings markets. CEO Greg Poux-Guillaume called the deal a "key milestone in executing our strategy" and expressed confidence in JSW Group's ability to drive growth for the acquired business.
JSW Paints Managing Director Parth Jindal highlighted the acquisition as a major boost to JSW, noting that ANIL’s premium brands like Dulux, International, and Sikkens would strengthen JSW’s position in one of India’s fastest-growing industries.
AkzoNobel expects net proceeds of €900 million, with €500 million earmarked for debt reduction and €400 million allocated to a share buyback program. The deal, involving up to 75% of ANIL's shares, is subject to regulatory approval and is set to close in Q4 2025.
2026-10-08
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Exit! Why Did Clariant Divest Its Venezuelan Business at a “Low Price”?
-
Supply Chain Resilience Reshapes Chemical Competition: What Lies Behind BASF’s Stable Outlook
-
BASF and Clariant Exit Quietly! Behind Henkel’s High-Priced Acquisition, Why Did Former Allies Choose to “Let Go”?
-
Geopolitical Conflict Drives Up Chemical Costs: The Industry Signal Behind DuPont’s Upgraded Outlook
-
Sun Pharma’s Organon Bid Would Redraw Indian Pharma M&A
-
Iran Conflict Leaves a Long Shadow on Drug Supply
-
AstraZeneca India Eyes ₹3,400 Crore Bengaluru Sale
-
McKinsey Pays to Close a Purdue Liability Chapter
-
The Most Striking Thing in BASF’s 2025 Results Isn’t Profit — It’s “Cutting Weight” and “Stopping the Bleeding” at the Same Time
-
BASF Moves to Sell 4,400 Employee Homes—Union Fury Reveals the Survival Math of a Chemical Giant
Recommend Reading
-
INEOS Shuts Down Europe's Last World-Scale Acetyl Production Facilities
-
AstraZeneca’s Wainua Fails Phase III Heart Trial, Wiping Out About $27 Billion in Market Value
-
Dover to Acquire Cloeren and Expand Its Polymer-Extrusion Equipment Portfolio
-
Huntsman Issues Two Consecutive MDI Price Hike Notices: €250 Increase in Europe, $300 Increase in India
-
argenx to Acquire Forte Biosciences for $2.2 Billion in Major Autoimmune Antibody Deal
-
Business Society September 23, 2026 PTA Trend Analysis: Volatility
-
Formic Acid Moving Averages Set to Cross Upward—Rising Trend May Be About to Begin
-
Melamine Stops Falling and Begins to Rebound; Short-Term Trend Strengthens; Golden Cross Awaits Confirmation
-
Short-term correction in lithium carbonate, medium to long-term logic remains unchanged
-
US-Iran Signals Easing, Plasticizer Supply Chain Stabilizes